Skip to main content

Table 1 Baseline patient characteristics

From: Baseline neutrophil-to-lymphocyte ratio (NLR) and derived NLR could predict overall survival in patients with advanced melanoma treated with nivolumab

 

N = 97

Gender, N (%), Female/Male

42 (43.2) / 55 (56.7)

Age, years, median (range)

61 (21–85)

Number of previous therapies, N (%)

 1

25 (25.8)

 2

48 (49.5)

  ≥ 3

24 (24.7)

Central nervous system (CNS) metastasis

27 (27.8)

Baseline lactate dehydrogenase, N (%)

  ≤ upper limit of normal (ULN)

50 (51.5)

  > ULN

45 (46.4)

 Unknown

2 (2.1)

B-RAF, N (%):

 Mutation

38 (39.1)

 Wild-Type

54 (55.7)

 Unknown

5 (5.2)